Genus (GNS.L)

Executive Summary

Genus plc is the global leader in animal genetics, operating through market-leading brands PIC (pork) and ABS (dairy and beef). The company applies advanced biotechnology and selective breeding to develop superior livestock genetics that enable farmers to produce high-quality protein more efficiently and sustainably. With a strong focus on innovation, including gene editing and genomic selection, Genus is positioned to address the rising global demand for protein while reducing environmental impact. As a publicly traded company (LSE: GNS) with a market capitalization of approximately $2 billion, Genus has a stable financial base and a proven business model. The company's strategic investments in research and development, particularly in disease-resistant traits and productivity gains, are expected to drive long-term growth. With operations in over 100 countries and a robust pipeline of genetic improvements, Genus is well-placed to capture value across the livestock supply chain.

Upcoming Catalysts (preview)

• Q4 2026Regulatory approval for PRRS-resistant pigs (gene-edited) in key markets60% success
• Q3 2026Q3 2026 earnings report with potential guidance upgrade70% success
• H1 2027Announcement of major partnership with a global food company for sustainable protein50% success